Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant.
Liu, Jinyan, Abishek Chandrashekar, Daniel Sellers, Julia Barrett, Michelle Lifton, Katherine McMahan, Michaela Sciacca, et al. 2022. “Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant.”. MedRxiv : The Preprint Server for Health Sciences.